Biological characteristics and antitumor activity of CIK cells activated by recombinant human fibronectin for human lung cancer cell lines in vitro

Chinese Journal of Lung Cancer

Volumn 13, Issue 4, 2010, Pages 277-281

  Wang, Shiyong ^a   Du, Weili ^a   Zhang, Hui ^a   Wulan, Tuya ^a   Zhang, Yuan ^a   He, Ying ^a   Yang, Yunfeng ^a   Liu, Sa ^a   Zhang, Zhe ^a   Wang, Jialing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD8+T cells subset; Cytokine induced killer (CIK) cells; Fibronectin

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; FIBRONECTIN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 4; PERFORIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE;

ANTIGENS, CD3; ANTIGENS, CD56; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINE-INDUCED KILLER CELLS; FIBRONECTINS; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-4; LUNG NEOPLASMS; RECEPTORS, IGG; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 77951596943     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.04.01     Document Type: Article

References (10)

1. Wang J, He M, Shi W, et al. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo. Cancer Invest, 2009, 27(3): 244-250.
2. Wu C, Jiang J, Shi L, et al. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer. Anticancer Res, 2008, 28(6B): 3997-4002.
3. Wang P, Yu JP, Gao SY, et al. Experimental study on the treatment of intracerebral glioma xenogra' with human cytokine-induced killer cells. Cell Immunol, 2008, 253(1-2): 59-65.
4. Kim HM, Kang JS, Lim J, et al. Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch Pharm Res, 2007, 30(11): 1464-1470.
5. Lili J, Yuchen S, Zhengtao W. The chemokine SDF-1alpha suppresses fibronectin-mediated in vitro lymphocytes adhesion. Mol Cells, 2006, 22(3): 308-313.
6. +T lymphocytes. J Immunol, 2007, 178(7): 4112-4119.
7. +T cells from a memory to memory/effector phenotype. J Immunol, 2002, 168(11): 5538-5550.
8. +T subsets with distinct replicative history and partial effector functions. Blood, 2003, 102(5): 1779-1787.
9. Linn YC, Lau SK, Liu BH, et al. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell. Immunology, 2009, 126(3): 423-435.
10. Wang SY, Zhang H, Du WL, et al. Clinical research on safety and therapeutic effects of CIK cells activated by retronectin for advanced malignant tumor patients. Chin J Clin Oncol, 2009, 36(20): 1163-1166.